|
This product requires a valid prescription
|
RAZADYNE ER is the new name of REMINYL (galantamine HBr), Reminyl is already recognized for its safety and effectiveness in helping to preserve his or her cognitive skills and their ability to accomplish daily living activities. Reminyl comes in a once-daily formulation, RAZADYNE ER (galantamine HBr). RAZADYNE ER contains the active ingredient galantamine and is available in three dosage strengths, Razadyne ER 8mg, Razadyne ER 16mg, and Razadyne ER 24mg extended-release capsules. Razadyne ER helps those with mild to moderate AD delay the progression of symptoms including thinking and memory. RAZADYNE ER has the added benefit of being an extended-release capsule, taken only once a day.
The RAZADYNE ER capsules contain a rate-controlling membrane that allows the medication to be released gradually over a 24-hour period. This new formulation contains an immediate and extended release dose that allows for the convenience of once-daily dosing. RAZADYNE ER is in a class of drugs called acetylcholinesterase inhibitors. Taken only once a day, the extended-release capsule is absorbed into the body consistently over a 24-hour period. Experts believe that RAZADYNE ER may block an enzyme that breaks down ACh in the brain, thereby making more ACh available. Your doctor will be able to tell you whether it is safe to take RAZADYNE ER with other medications. Please inform your physician of any prescriptions, over- the-counter medication, vitamins, and herbal or dietary supplements that you may be taking. Razadyne ER Side Effects: In clinical trials, the most frequent adverse events with RAZADYNE ER were similar to those seen with RAZADYNE. The most common Razadyne ER side effects are nausea, vomiting, diarrhea, loss of appetite, and weight loss. Typically, these Razadyne ER side effects are mild and temporary. Razadyne ER may not be for everyone. Some people experience a slowed heart rate, which may lead to fainting. Serious stomach problems can occur in people taking medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or those at risk for stomach ulcers. REMINYL'S NAME HAS CHANGED TO RAZADYNE DUE TO PRESCRIBING ERRORS: Rare but serious prescribing errors occurred due to confusion between REMINYL and AMARYL (glimepiride), a medication for Type 2 diabetes. To prevent further errors or confusion, Reminyl drugs name has changed REMINYL to RAZADYNE. The most common adverse side effects with Razadyne ER were similar to those seen with Reminyl. The most common Razadyne ER side effects are nausea, vomiting, diarrhea, loss of appetite, and weight loss. Typically, these Razadyne ER side effects are mild and temporary. Razadyne ER may not be for everyone. Some people experience a slowed heart rate, which may lead to fainting. Serious stomach problems can occur in people taking medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or those at risk for stomach ulcers. Razadyne ER is now available from Canada. Razadyne ER is called Reminyl ER in Canada. |
 |
  |
|